GRP
CRSP icon

Global Retirement Partners’s CRISPR Therapeutics CRSP Stock Holding History

Global Retirement Partners’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.9K Buy
+1,153
New +$60.8K ﹤0.01% 2369
2025
Q4 		$81K Buy
1,545
+567
+58% +$34K ﹤0.01% 2040
2025
Q3 		$63.4K Hold
978
– – ﹤0.01% 1771
2025
Q2 		$47.6K Buy
+978
New +$37.8K ﹤0.01% 1800
2024
Q4 		$38.7K Sell
984
-1,291
-57% -$61K ﹤0.01% 1749
2024
Q3 		$107K Hold
2,275
– – ﹤0.01% 1207
2024
Q2 		$123K Hold
2,275
– – ﹤0.01% 1093
2024
Q1 		$155K Hold
2,275
– – 0.01% 892
2023
Q4 		$144K Buy
2,275
+725
+47% +$40.1K 0.01% 884
2023
Q3 		$64.5K Hold
1,550
– – ﹤0.01% 1141
2023
Q2 		$87K Hold
1,550
– – ﹤0.01% 1007
2023
Q1 		$76.2K Buy
1,550
+1,500
+3,000% +$72.9K ﹤0.01% 1037
2022
Q4 		$2.03K Hold
50
– – ﹤0.01% 2359
2022
Q3 		$3K Hold
50
– – ﹤0.01% 2078
2022
Q2 		$3K Hold
50
– – ﹤0.01% 2036
2022
Q1 		$3K Sell
50
-107
-68% -$6.72K ﹤0.01% 2035
2021
Q4 		$12K Sell
157
-250
-61% -$21.8K 0.01% 143
2021
Q3 		$46K Sell
407
-100
-20% -$12.6K ﹤0.01% 884
2021
Q2 		$82K Hold
507
– – 0.01% 688
2021
Q1 		$62K Buy
507
+354
+231% +$53.5K 0.01% 705
2020
Q4 		$23K Buy
+153
New +$18.1K ﹤0.01% 982

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Global Retirement Partners's CRSP Position: Q2 2026 in Review

Global Retirement Partners opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 1,153 shares worth $62.9K. The stake represents ﹤0.01% of the portfolio and ranks #2369 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CRSP as recently as Q4 2025.

Global Retirement Partners first reported a position in CRSP in Q4 2020 and has held it in 21 quarters since. The position peaked at $155K in Q1 2024. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Global Retirement Partners held 1,153 shares of CRISPR Therapeutics worth $62.9K as of Q2 2026.
  • CRISPR Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2369 holding.
  • Global Retirement Partners first reported a position in CRISPR Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Global Retirement Partners's CRISPR Therapeutics position peaked at $155K in Q1 2024.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.